Bill Text: MN HF2402 | 2013-2014 | 88th Legislature | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Omnibus health and human services policy bill.

Spectrum: Slight Partisan Bill (Democrat 2-1)

Status: (Passed) 2014-05-21 - Secretary of State Chapter 291 [HF2402 Detail]

Download: Minnesota-2013-HF2402-Introduced.html

1.1A bill for an act
1.2relating to health; specifying the protocol for pharmacist administration of
1.3vaccines;amending Minnesota Statutes 2012, section 151.01, subdivision 27.

1.5    Section 1. Minnesota Statutes 2012, section 151.01, subdivision 27, is amended to read:
1.6    Subd. 27. Practice of pharmacy. "Practice of pharmacy" means:
1.7    (1) interpretation and evaluation of prescription drug orders;
1.8    (2) compounding, labeling, and dispensing drugs and devices (except labeling by
1.9a manufacturer or packager of nonprescription drugs or commercially packaged legend
1.10drugs and devices);
1.11    (3) participation in clinical interpretations and monitoring of drug therapy for
1.12assurance of safe and effective use of drugs;
1.13    (4) participation in drug and therapeutic device selection; drug administration for first
1.14dosage and medical emergencies; drug regimen reviews; and drug or drug-related research;
1.15    (5) participation in administration of influenza vaccines to all eligible individuals ten
1.16years of age and older and all other vaccines to patients 18 years of age and older under
1.17standing orders from a physician licensed under chapter 147 or by written protocol with a
1.18physician licensed under chapter 147, a physician assistant authorized to prescribe drugs
1.19under chapter 147A, or an advanced practice nurse authorized to prescribe drugs under
1.20section 148.235, provided that:
1.21    (i) the protocol includes, at a minimum:
1.22    (A) the name, dose, and route of each vaccine that may be given;
1.23    (B) the patient population for whom the vaccine may be given;
1.24    (C) contraindications and precautions to the vaccine;
2.1    (D) the procedure for handling an adverse reaction;
2.2    (E) the name, signature, and address of the physician, physician assistant, or
2.3advanced practice nurse;
2.4    (F) a telephone number at which the physician, physician assistant, or advanced
2.5practice nurse can be contacted; and
2.6    (G) the date and time period for which the protocol is valid;
2.7    (ii) the pharmacist is trained in has successfully completed a program approved
2.8by the American Accreditation Council of Pharmaceutical for Pharmacy Education,
2.9specifically for the administration of immunizations, or graduated from a college of
2.10pharmacy in 2001 or thereafter a program approved by the board; and
2.11    (ii) (iii) the pharmacist reports the administration of the immunization to the patient's
2.12primary physician or clinic, or to the Minnesota Immunization Information Connection; and
2.13(iv) the pharmacist complies with guidelines for vaccines and immunizations
2.14established by the federal Advisory Committee on Immunization Practices (ACIP), except
2.15that a pharmacist does not need to comply with those portions of the guidelines that establish
2.16immunization schedules when administering a vaccine pursuant to a valid prescription
2.17order issued by a physician licensed under chapter 147, a physician assistant authorized to
2.18prescribe drugs under chapter 147A, or an advanced practice nurse authorized to prescribe
2.19drugs under section 148.235, provided that the prescription drug order is consistent with
2.20United States Food and Drug Administration-approved labeling of the vaccine;
2.21    (6) participation in the practice of managing drug therapy and modifying drug
2.22therapy, according to section 151.21, subdivision 1, according to a written protocol
2.23between the specific pharmacist and the individual dentist, optometrist, physician,
2.24podiatrist, or veterinarian who is responsible for the patient's care and authorized to
2.25independently prescribe drugs. Any significant changes in drug therapy must be reported
2.26by the pharmacist to the patient's medical record;
2.27    (7) participation in the storage of drugs and the maintenance of records;
2.28    (8) responsibility for participation in patient counseling on therapeutic values,
2.29content, hazards, and uses of drugs and devices; and
2.30    (9) offering or performing those acts, services, operations, or transactions necessary
2.31in the conduct, operation, management, and control of a pharmacy.